AnOpIva
Uppsala, Uppsa, 75309, Sweden
Location status: Recruiting
NCT Number: NCT06512129
The goal of this observational study is to learn about the influence of extracellular water on volume status in adult sepsis patients presenting with hemodynamic instability. The main question it aims to answer is:
• Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult sepsis patients.
Patients with sepsis admitted to intensive care will receive standard care with the addition of measurement of extracellular water.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Uppsala, Uppsa, 75309, Sweden
Location status: Recruiting
Adult patients with sepsis admitted to any of our ICUs will be recruited. During the first three days after inclusion blood samples and extended non-invasive monitoring, including monitoring of the microcirculation (CytoCam) and measurement of extracellular water (dielectronic constant), will be added to routine care and monitoring.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 days
Can measurement of extracellular water (MoistureMeterD, Delfin Technologies Ltd, Kuopio, Finland) contribute to the description of hemodynamic instability in adult sepsis patients during the first 72 hours?
Contact information is provided by the study sponsor or research team.
Uppsala University
Other
Phenotypes in Sepsis - Extracellular Water for Volume Status Characterization
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06562803
Acute-On-Chronic Liver Failure, Digestive System Diseases
Guangzhou, Guangdong, China
View Trial DetailsNCT07711535
Infections, Inflammation
Kumasi, Ghana
View Trial DetailsNCT07670624
Biomarker Discovery, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Wroclaw, Poland
View Trial DetailsNCT07215702
Acute Kidney Injury, Female Urogenital Diseases
Newport Beach, California, United States
View Trial Details